BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24076100)

  • 41. Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species.
    López-González I; Schlüter A; Aso E; Garcia-Esparcia P; Ansoleaga B; LLorens F; Carmona M; Moreno J; Fuso A; Portero-Otin M; Pamplona R; Pujol A; Ferrer I
    J Neuropathol Exp Neurol; 2015 Apr; 74(4):319-44. PubMed ID: 25756590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Wirths O; Weis J; Szczygielski J; Multhaup G; Bayer TA
    Acta Neuropathol; 2006 Apr; 111(4):312-9. PubMed ID: 16520967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
    Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP
    J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypoxia-up-regulated mitochondrial movement regulator does not contribute to the APP/PS1 double transgenic mouse model of Alzheimer's disease.
    Zou Y; Li Y; Yu W; Du Y; Shi R; Zhang M; Duan J; Deng Y; Tu Q; Dai R; Lü Y
    Dement Geriatr Cogn Disord; 2013; 36(3-4):137-45. PubMed ID: 23900018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of hippocampal N-acetyl aspartate level in aged APP(Swe)/PS1(dE9) transgenic mice is associated with degeneration of CA3 pyramidal neurons.
    Xu W; Zhan Y; Huang W; Wang X; Zhang S; Lei H
    J Neurosci Res; 2010 Nov; 88(14):3155-60. PubMed ID: 20806406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.
    Ando K; Leroy K; Héraud C; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
    Am J Pathol; 2011 Feb; 178(2):803-16. PubMed ID: 21281813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.
    Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM
    Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of Endothelial Nitric Oxide Synthase Promotes p25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer's Disease.
    Austin SA; Katusic ZS
    Circ Res; 2016 Oct; 119(10):1128-1134. PubMed ID: 27601478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
    Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S
    Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
    Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.
    Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H
    J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
    J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Age-dependent expression of HSP90 in the hippocampus of APP/PS1 mice].
    Wang BY; Liu SY; Hao KM; Qi WX
    Sheng Li Xue Bao; 2024 Apr; 76(2):257-265. PubMed ID: 38658375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TDP-43 expression influences amyloidβ plaque deposition and tau aggregation.
    Davis SA; Gan KA; Dowell JA; Cairns NJ; Gitcho MA
    Neurobiol Dis; 2017 Jul; 103():154-162. PubMed ID: 28416393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
    Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y
    Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.